flibanserin: Clinical Trials

18 trials of flibanserin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 7 terminated, 1 active not recruiting. 10 Phase 3, 3 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 310Completed 6, Terminated 4
Phase 13Completed 3
Phase 23Active not recruiting 1, Completed 1, Terminated 1
Not applicable1Terminated 1
Phase 41Terminated 1

Follow flibanserin: new trials by email Literature Review of flibanserin trials Research Report on flibanserin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
Flibanserin 100 MG, Placebo, Androgen deprivation therapy - Prostate Adenocarcinoma
Phase 2CompletedAndrew McDonald442021-07-022026-07-20
Hypoactive Sexual Desire Disorder in Males
Flibanserin, Placebo - Low Libido
Phase 2TerminatedMohit Khera82020-05-082026-01-26
Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)
Flibanserin 100Mg Tab, Flibanserin 100 MG [Addyi] - Healthy
Phase 1CompletedGenuine Research Center, Egypt262018-12-122020-07-31
A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors
Flibanserin Pill - Breast Cancer, Hyposexual Desire Disorder
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center432018-09-142026-11-04
Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
sex therapy, flibanserin - Hypoactive Sexual Desire Disorder
Phase 4TerminatedSan Diego Sexual Medicine232017-01-252022-06-13
Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
Flibanserin, Placebo - Hypoactive Sexual Desire Disorder
Not applicableTerminatedUniversity of Chicago572016-10-012024-05-16
Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
flibanserin 100 mg dose every evening - Sexual Dysfunctions, Psychological
Phase 1CompletedSprout Pharmaceuticals, Inc242010-07-012014-05-21
to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
Flibanserin plus Digoxin, Digoxin - Healthy
Phase 1CompletedBoehringer Ingelheim242010-06-012011-04-08
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
flibanserin - Sexual Dysfunctions, Psychological
Phase 3TerminatedSprout Pharmaceuticals, Inc5962010-04-012014-05-12
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
flibanserin 50 mg to 100 mg qhs, flibanserin 100 mg qhs, placebo 2 tablets qhs - Sexual Dysfunctions, Psychological, Depression
Phase 3TerminatedSprout Pharmaceuticals, Inc1112010-01-012016-08-24
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
Flibanserin, Placebo - Sexual Dysfunctions, Psychological
Phase 3TerminatedSprout Pharmaceuticals, Inc7482010-01-012014-06-17
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
flibanserin, placebo - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc9492009-10-012014-06-12
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
Flibanserin, Placebo - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc10902009-10-012014-05-19
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
Flibanserin - Sexual Dysfunctions, Psychological
Phase 3TerminatedSprout Pharmaceuticals, Inc17232007-02-012014-06-13
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
flibanserin, flibanserin 50mg, flibanserin 100mg - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc15842006-07-012016-06-27
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
flibanserin - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc8802006-07-012016-06-27
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
flibanserin, placebo - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc13852006-07-012016-06-27
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
Flibanserin - Sexual Dysfunctions, Psychological
Phase 3CompletedSprout Pharmaceuticals, Inc7492006-01-012012-03-16

Conditions studied

Sexual Dysfunctions, Psychological (13)  ·  Breast Neoplasms (1)  ·  Depression (1)  ·  Erectile Dysfunction (1)

Sponsors

Sprout Pharmaceuticals, Inc (11)  ·  Andrew McDonald (1)  ·  Boehringer Ingelheim (1)  ·  Genuine Research Center, Egypt (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Mohit Khera (1)  ·  San Diego Sexual Medicine (1)  ·  University of Chicago (1)

Countries

United States (16)  ·  Canada (6)  ·  Egypt (1)  ·  Germany (1)

Top investigators

Ahmed Elshafeey, Ph.D. Pharma (1)  ·  Andrew McDonald, MD (1)  ·  Irwin Goldstein, MD (1)  ·  Jon E Grant, MD, JD, MPH (1)  ·  Mohit Khera, MD, MBA, MPH (1)  ·  Shari Goldfarb, MD (1)  ·  Stephanie Cacioppo, PhD (1)

Results publications

PMID 22239862, PMID 22248038, PMID 23057791, PMID 24281236, PMID 28583342, PMID 29502984

NIH funding

R21CA259808 (1)